Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial.
Amira S A SaidRaghda R S HusseinDoaa Mahmoud KhalilAlzhraa M FahmyAhmed H A HassaneinLamiaa N AbdelatyPublished in: Pharmacy practice (2022)
These findings suggest that Enoxaparin was safe, effective, and well tolerated and has a role in decreasing the progression of the disease and its complications while HCQ did not discover any evidence of extra therapeutic benefits.